Dr. Scott Gottlieb

Former FDA Commissioner Dr. Scott Gottlieb spoke on CNBC Thursday about Gilead's (NASDAQ: GILD) remdesivir trial. Enough data is likely accumulated at this point that the regulatory agency might consider making the drug available under the emergency use authorization or through...